Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 40kWORD 9k
11 September 2020
P-004985/2020
Priority question for written answer
to the Commission
Rule 138
Tomislav Sokol (PPE)
 Subject: Product safety in the Single Market

Protecting the health and safety of citizens is an absolute priority for all European institutions. The outbreak of the pandemic has increased demand for protective medical equipment, such as masks. Participating in an exchange of views with members of the Committee on the Internal Market and Consumer Protection (IMCO), Didier Reynders, the Commissioner for Justice, said that eight Member States had reported more than 7 million unsafe masks via the RAPEX system, which were subsequently recalled from the Single Market. In the light of this:

1. Precisely which Member States reported unsafe masks via the RAPEX system, as Commissioner Reynders said?

2. Where were these masks produced?

3. What is the simplest way for consumers to identify a mask that falls short of safety standards?

Original language of question: HR
Last updated: 16 September 2020Legal notice - Privacy policy